(Q61862231)
Statements
A Phase III, Randomized, Open Label Study Evaluating the Safety of Apixaban in Subjects With Cancer Related Venous Thromboembolism (English)
0 references
20 November 2015
0 references
20 November 2019
0 references
315
0 references
18 year
0 references